The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

Clinical trials start with Phase I to assess drug safety in a small group. Phase II tests effectiveness and side effects on a larger group. Phase III compares the new drug to existing treatments ...

Analysts at Truist Securities admitted that the result for itepekimab, which the companies were hoping to follow their ...

The new approach would help improve drug safety, lower research and development costs and drug ... which are expected to be rolled out in phases.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Despite mixed results, analysts maintained faith in ivonescimab’s ability to cross over between Eastern and Western patient ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Deepak Bhamidipati, MD, discusses a review conducted to investigate how the design of early-phase clinical trials has evolved ...

Keros Therapeutics, Inc. (NASDAQ:KROS) has announced it will discontinue all development of cibotercept (KER-012) for ...

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...